Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 3/20 | 0.39 |
| ▸ | CD44 | P16070 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 5/20 | 0.36 |
| ▸ | RAB9A | P51151 | 4/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | PARP1 | P09874 | 1/20 | 0.36 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.35 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.33 |
| ▸ | WEE1 | P30291 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | KIT | P10721 | 1/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.33 |
| ▸ | FLT3 | P36888 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1838861 | 0.85 | ALDH1A1 (0.50) | ADORA2ANPC1RAB9AMEN1KMT2A | |
| SCHEMBL4553387 | 0.83 | CHEK1 (0.41) | ADORA2ACD44NPC1RAB9AMEN1 | |
| SCHEMBL2602432 | 0.82 | CD44 (0.48) | ADORA2ACD44NPC1RAB9AMEN1 | |
| SCHEMBL29414657 | 0.82 | CD44 (0.48) | ADORA2ACD44NPC1RAB9AMEN1 | |
| SCHEMBL28621174 | 0.81 | ALDH1A1 (0.43) | ADORA2ACD44NPC1RAB9AMEN1 | |
| SCHEMBL28409364 | 0.80 | DRD1 (0.37) | ADORA2AALDH1A1HSD17B10 | |
| SCHEMBL8397637 | 0.77 | CD44 (0.42) | ADORA2ACD44NPC1RAB9AADORA3 | |
| SCHEMBL4843094 | 0.77 | ADORA2A (0.50) | ADORA2ACD44NPC1RAB9AMEN1 | |
| SCHEMBL7164278 | 0.74 | ALDH1A1 (0.42) | ADORA2ANPC1RAB9AMEN1KMT2A | |
| Ammonia Solution, Strong SCHEMBL2406827 | 0.73 | MEN1 (0.47) | ADORA2ANPC1RAB9AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8021811-B2 | Photoreceptor and method of making same | XEROX CORPORATION (US) | 2011-09-20 | — | — | US | disclosed |
| US-8003288-B2 | Self-healing photoreceptor | XEROX CORPORATION (US) | 2011-08-23 | — | — | US | disclosed |
| US-7960082-B2 | Photoreceptor protective overcoat layer including silicone polyether and method of making same | XEROX CORPORATION (US) | 2011-06-14 | — | — | US | disclosed |
| US-7935465-B2 | Self lubricating photoreceptor | XEROX CORPORATION (US) | 2011-05-03 | — | — | US | disclosed |
| US-7879518-B2 | includes substrate, charge generating layer, and charge transport layer having N,N,N'N'-tetra(4-methylphenyl)-(1,1'-biphenyl)-4,4'-diamine charge transport molecule antioxidant selected to match oxidation potential of charge transport molecule such as sterically hindered bis-phenols and dihydroquinones | XEROX CORPORATION (US) | 2011-02-01 | — | — | US | disclosed |
| US-20090226828-A1 | SELF-HEALING PHOTORECEPTOR | XEROX CORPORATION (US) | 2009-09-10 | — | — | US | disclosed |
| US-20090220876-A1 | SELF LUBRICATING PHOTORECEPTOR | XEROX CORPORATION (US) | 2009-09-03 | — | — | US | disclosed |
| US-20090186287-A1 | PHOTORECEPTOR AND METHOD OF MAKING SAME | XEROX CORPORATION (US) | 2009-07-23 | — | — | US | disclosed |
| US-20090130575-A1 | PHOTORECEPTOR | XEROX CORPORATION (US) | 2009-05-21 | — | — | US | disclosed |
| US-20080299474-A1 | HIGH QUALITY SUBSTITUTED ARYL DIAMINE AND A PHOTORECEPTOR | XEROX CORPORATION (US) | 2008-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080299474-A1 | HIGH QUALITY SUBSTITUTED ARYL DIAMINE AND A PHOTORECEPTOR | NR2E3, XPA, PRPH | ADORA2A 560/4885CD44 4802/4885NPC1 1686/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.